Nissay Asset Management Corp Teva Pharmaceutical Industries LTD Transaction History

Nissay Asset Management Corp

  • $15 Billion
  • Q1 2025

A detailed history of Nissay Asset Management Corp transactions in Teva Pharmaceutical Industries LTD stock. As of the latest transaction made, Nissay Asset Management Corp holds 138,386 shares of TEVA stock, worth $2.42 Million. This represents 0.01% of its overall portfolio holdings.

Number of Shares
138,386
Previous 139,049 0.48%
Holding current value
$2.42 Million
Previous $3.06 Million 30.61%
% of portfolio
0.01%
Previous 0.02%

Shares

30 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2025

May 15, 2025
SELL
$14.67 - $22.01 $9,726 - $14,592
-663 Reduced 0.48%
138,386 $2.13 Million
Q4 2024

Feb 14, 2025
BUY
$16.43 - $22.77 $25,877 - $35,862
1,575 Added 1.15%
139,049 $3.06 Million
Q3 2024

Nov 14, 2024
BUY
$15.81 - $18.96 $56,868 - $68,199
3,597 Added 2.69%
137,474 $2.48 Million
Q2 2024

Aug 14, 2024
BUY
$12.78 - $17.4 $39,183 - $53,348
3,066 Added 2.34%
133,877 $2.18 Million
Q1 2024

May 15, 2024
BUY
$10.67 - $14.43 $21,083 - $28,513
1,976 Added 1.53%
130,811 $1.85 Million
Q4 2023

Feb 14, 2024
BUY
$8.12 - $10.63 $41,395 - $54,191
5,098 Added 4.12%
128,835 $1.35 Million
Q3 2023

Nov 14, 2023
BUY
$7.48 - $10.7 $34,841 - $49,840
4,658 Added 3.91%
123,737 $1.26 Million
Q2 2023

Aug 14, 2023
SELL
$7.2 - $9.47 $12,744 - $16,761
-1,770 Reduced 1.46%
119,079 $896,000
Q1 2023

May 15, 2023
SELL
$8.36 - $11.37 $38,364 - $52,176
-4,589 Reduced 3.66%
120,849 $1.07 Million
Q4 2022

Feb 14, 2023
SELL
$7.95 - $9.48 $48,121 - $57,382
-6,053 Reduced 4.6%
125,438 $1.14 Million
Q3 2022

Nov 14, 2022
BUY
$6.86 - $11.95 $35,006 - $60,980
5,103 Added 4.04%
131,491 $1.06 Million
Q2 2022

Aug 15, 2022
SELL
$7.38 - $10.4 $8,811 - $12,417
-1,194 Reduced 0.94%
126,388 $950,000
Q1 2022

May 16, 2022
BUY
$7.33 - $9.39 $16,367 - $20,967
2,233 Added 1.78%
127,582 $1.2 Million
Q4 2021

Feb 14, 2022
BUY
$7.9 - $10.19 $40,266 - $51,938
5,097 Added 4.24%
125,349 $1 Million
Q3 2021

Nov 10, 2021
BUY
$8.38 - $10.18 $37,173 - $45,158
4,436 Added 3.83%
120,252 $1.17 Million
Q2 2021

Aug 13, 2021
SELL
$9.9 - $11.56 $62,152 - $72,573
-6,278 Reduced 5.14%
115,816 $1.15 Million
Q1 2021

May 11, 2021
BUY
$10.34 - $12.81 $17,671 - $21,892
1,709 Added 1.42%
122,094 $1.41 Million
Q4 2020

Feb 08, 2021
BUY
$8.61 - $11.04 $28,344 - $36,343
3,292 Added 2.81%
120,385 $1.16 Million
Q3 2020

Oct 20, 2020
SELL
$8.57 - $12.69 $265,215 - $392,717
-30,947 Reduced 20.9%
117,093 $1.06 Million
Q2 2020

Jul 27, 2020
SELL
$8.12 - $13.12 $164,559 - $265,889
-20,266 Reduced 12.04%
148,040 $1.83 Million
Q1 2020

May 05, 2020
BUY
$6.69 - $13.45 $459,603 - $924,015
68,700 Added 68.97%
168,306 $1.51 Million
Q4 2019

Feb 14, 2020
BUY
$6.53 - $10.72 $9,396 - $15,426
1,439 Added 1.47%
99,606 $976,000
Q3 2019

Nov 14, 2019
SELL
$6.16 - $9.6 $401,859 - $626,275
-65,237 Reduced 39.92%
98,167 $675,000
Q2 2019

Aug 07, 2019
BUY
$8.12 - $15.72 $231,111 - $447,422
28,462 Added 21.09%
163,404 $1.51 Million
Q1 2019

May 03, 2019
SELL
$15.58 - $20.01 $126,462 - $162,421
-8,117 Reduced 5.67%
134,942 $2.12 Million
Q4 2018

Feb 06, 2019
BUY
$14.59 - $23.84 $53,691 - $87,731
3,680 Added 2.64%
143,059 $2.21 Million
Q3 2018

Oct 30, 2018
BUY
$21.06 - $25.65 $368,486 - $448,798
17,497 Added 14.36%
139,379 $3 Million
Q2 2018

Aug 08, 2018
BUY
$16.77 - $24.71 $13,617 - $20,064
812 Added 0.67%
121,882 $2.96 Million
Q1 2018

May 14, 2018
BUY
$16.68 - $22.07 $734,353 - $971,653
44,026 Added 57.14%
121,070 $2.07 Million
Q4 2017

Feb 14, 2018
BUY
$11.23 - $19.1 $865,204 - $1.47 Million
77,044
77,044 $1.46 Million

Others Institutions Holding TEVA

# of Institutions
660
Shares Held
626M
Call Options Held
27.9M
Put Options Held
21.8M
View Full List

About TEVA PHARMACEUTICAL INDUSTRIES LTD

TEVA Quotes by TradingView
  • Ticker TEVA
  • Exchange OTC
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 1,110,560,000
  • Market Cap $19.4B
  • Description
  • Teva Pharmaceutical Industries Limited, a pharmaceutical company, develops, manufactures, markets, and distributes generic medicines, specialty medicines, and biopharmaceutical products in North America, Europe, and internationally. The company offers sterile products, hormones, high-potency drugs, and cytotoxic substances in various dosage form...
More about TEVA
Track This Portfolio

Track Nissay Asset Management Corp Portfolio

Follow Nissay Asset Management Corp and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Nissay Asset Management Corp , based on Form 13F filings with the SEC.

News

Stay updated on Nissay Asset Management Corp with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email